Verve Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q3 2021 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Verve Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q3 2021 to Q2 2024.
- Verve Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending June 30, 2024 was $11.2M, a 3.15% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)